These genetic markers (FLT3-ITD, E2A-PBX1, DNMT3A, HOX11, and RUNX1) are anticipated to become early warning indicators for ICU transfer or short-term mortality in ALL patients, providing critical insights into poor prognosis and imminent death. This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.